Patent US5084002A successfully refreshed from Google Patents.
US5084002A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ultra-thin high dose iridium source for remote afterloader
Assignee: Abbott Cardiovascular Systems Inc
•
Filing: 1988-08-04
•
Granted: 1992-01-28
•
Expires: 2008-08-04
Abstract
Abstract An ultra-thin iridium source is used for the treatment of cancerous tissue, particularly in areas of the human body, such as the brain, where minimization of trauma to adjacent tissue is a high priority. The source is formed of a relatively pure iridium seed encapsulated in the end region of a relatively pure unitary platinum delivery wire. The relatively pure iridium source is irradiated to a high activity level (e.g. 10 curie) even though having a short overall length (e.g. 10 millimeter) and ultra-thin diameter (e.g. about 1/8 millimeter). The platinum delivery wire defines a substantially uniform ultra-thin cross section of approximately 0.5 millimeter diameter. The iridium source is formed within the unitary platinum delivery wire without resort to welding or other inherently unreliable attachment systems. Delivery of the high activity pure iridium source to treatment area is achieved using remote afterloader equipment.
Inventors
- 👤 Samuel F. Liprie
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 11:50
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/10; A61N5/1001; A61N5/1027; A61N2005/1019; A61N2005/1025
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
136 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: an elongate unitary delivery wire having a treatment end; and an iridium core member encapsulated within the treatment end of the said elongate unitary delivery wire, said iridium core member being radioactive from irradiation of the assembled elongate unitary delivery wire and iridium core member by thermal neutrons, the materials of said iridium core member and elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 2
Dependent Claim
136 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: an elongate unitary delivery wire having a treatment end; and an iridium core member encapsulated within the treatment end of the said elongate unitary delivery wire, said iridium core member being radioactive from irradiation of the assembled elongate unitary delivery wire and iridium core member by thermal neutrons, the materials of said iridium core member and elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 3
Dependent Claim
32 words
A high activity, ultra-thin radiation source assembly according to claim 1 wherein said iridium core member consists of relatively pure iridium and said elongate unitary delivery wire consists of relatively pure platinum.
Claim 4
Dependent Claim
156 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: an elongate unitary delivery wire having a treatment end, said elongate unitary delivery wire being round and substantially less than one millimeter in diameter at the treatment end; and an iridium core member encapsulated within the treatment end of the said elongate unitary delivery wire, said iridium core member being radioactive from irradiation of the assembled elongate unitary delivery wire and said iridium core member by thermal neutrons, the materials of said iridium core member and elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 5
Dependent Claim
156 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: an elongate unitary delivery wire having a treatment end, said elongate unitary delivery wire being round and substantially less than one millimeter in diameter at the treatment end; and an iridium core member encapsulated within the treatment end of the said elongate unitary delivery wire, said iridium core member being radioactive from irradiation of the assembled elongate unitary delivery wire and said iridium core member by thermal neutrons, the materials of said iridium core member and elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 6
Dependent Claim
29 words
A high activity, ultra-thin radiation source assembly according to claim 3 wherein said elongate unitary delivery wire is about 0.5 millimeters in diameter at least at the treatment end.
Claim 7
Dependent Claim
32 words
A high activity, ultra-thin radiation source assembly according to claim 3, wherein said iridium core member is no longer than about 10 millimeters and is activated to at least about 10 curies.
Claim 8
Dependent Claim
144 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: an elongate unitary delivery wire having a treatment end; and a relatively pure iridium core member encapsulated within the treatment end of the said elongate unitary delivery wire, said relatively pure iridium core member being radioactive from irradiation of the assembled elongate unitary delivery wire and relatively pure iridium core member by thermal neutrons, the materials of said relatively pure iridium core member and elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 9
Dependent Claim
144 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: an elongate unitary delivery wire having a treatment end; and a relatively pure iridium core member encapsulated within the treatment end of the said elongate unitary delivery wire, said relatively pure iridium core member being radioactive from irradiation of the assembled elongate unitary delivery wire and relatively pure iridium core member by thermal neutrons, the materials of said relatively pure iridium core member and elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 10
Dependent Claim
29 words
A high activity, ultra-thin radiation source assembly according to claim 6 wherein said elongate unitary delivery wire is about 0.5 millimeters in diameter at least at the treatment end.
Claim 11
Dependent Claim
34 words
A high activity, ultra-thin radiation source assembly according to claim 6 wherein said relatively pure iridium core member is no longer than about 10 millimeters and is activated to at least about 10 curies.
Claim 12
Dependent Claim
147 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: a relatively pure platinum elongate unitary delivery wire having a treatment end; and an iridium core member encapsulated within the treatment end of said relatively pure platinum elongate unitary delivery wire, said iridium core member being radioactive from irradiation of the assembled relatively pure platinum elongate unitary delivery wire and iridium core member by thermal neutrons, the materials of said iridium core member and relatively pure platinum elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 13
Dependent Claim
147 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: a relatively pure platinum elongate unitary delivery wire having a treatment end; and an iridium core member encapsulated within the treatment end of said relatively pure platinum elongate unitary delivery wire, said iridium core member being radioactive from irradiation of the assembled relatively pure platinum elongate unitary delivery wire and iridium core member by thermal neutrons, the materials of said iridium core member and relatively pure platinum elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 14
Dependent Claim
32 words
A high activity, ultra-thin radiation source assembly according to claim 9 wherein said relatively pure platinum elongate unitary delivery wire is about 0.5 millimeters in diameter at least at the treatment end.
Claim 15
Dependent Claim
32 words
A high activity, ultra-thin radiation source assembly according to claim 9 wherein said iridium core member is no longer than about 10 millimeters and is activated to at least about 10 curies.
Claim 16
Dependent Claim
181 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: a relatively pure platinum elongate unitary delivery wire having a treatment end, said relatively pure platinum elongate unitary delivery wire being round and substantially less than one millimeter in diameter at the treatment end; and a relatively pure iridium core member encapsulated within the treatment end of the said relatively pure platinum elongate unitary delivery wire, said relatively pure iridium core member being radioactive from irradiation of the assembled relatively pure platinum elongate unitary delivery wire and said relatively pure iridium core member by thermal neutrons, the materials of said relatively pure iridium core member and relatively pure platinum elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said relatively pure iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 17
Dependent Claim
181 words
A high activity, ultra-thin radiation source assembly for the nonresident treatment of cancerous tissue within a living body with minimum damage to surrounding normal tissue and for insertion into the living body through an ultra-thin guide tube by a remote controlled afterloader apparatus, comprising: a relatively pure platinum elongate unitary delivery wire having a treatment end, said relatively pure platinum elongate unitary delivery wire being round and substantially less than one millimeter in diameter at the treatment end; and a relatively pure iridium core member encapsulated within the treatment end of the said relatively pure platinum elongate unitary delivery wire, said relatively pure iridium core member being radioactive from irradiation of the assembled relatively pure platinum elongate unitary delivery wire and said relatively pure iridium core member by thermal neutrons, the materials of said relatively pure iridium core member and relatively pure platinum elongate unitary delivery wire other than iridium being substantially nonradioactive relative to the activity of iridium 192 in said relatively pure iridium core member within a time after said irradiation short relative to the half-life of iridium 192.
Claim 18
Dependent Claim
32 words
A high activity, ultra-thin radiation source assembly according to claim 12 wherein said relatively pure platinum elongate unitary delivery wire is about 0.5 millimeters in diameter at least at the treatment end.
Claim 19
Dependent Claim
34 words
A high activity, ultra-thin radiation source assembly according to claim 12 wherein said relatively pure iridium core member is no longer than about 10 millimeters and is activated to at least about 10 curies.
References Cited (Backward Citations)
US1753287A
Cited
US1954868A
Cited
US2322902A
Cited
US2429438A
Cited
US2546761A
Cited
US2798164A
Cited
GB857992A
Cited
US3060924A
Cited
US3438365A
Cited
US3485234A
Cited
US3612058A
Cited
US3674006A
Cited
US3749086A
Cited
US3924632A
Cited
US4096862A
Cited
US4190461A
Cited
US4425919A
Cited
US4554929A
Cited
US4538622A
Cited
US4584991A
Cited
US4815449A
Cited
US4819618A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-01-27 | 1995-07-29 | 1996-01-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-01-27 | 1999-07-29 | 2000-01-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-01-27 | 2003-07-29 | 2004-01-28 | $7700.00 | Window Closed / Lapsed |